Business
Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price was in reverse today after surging more than 11% on Monday. The allogeneic cellular medicines company announced a trial update to its rexlemestrocel-L drug.
At the closing bell, Mesoblast shares finished the day down 8.68%…
Continue Reading
-
General24 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General24 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation
-
General22 hours agoa pivotal moment in Liberal power struggle
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points